Dihydrotestosterone: A rationale for its use as a non-aromatizable androgen replacement therapeutic agent

1998/10/01 by Ronald S. Swerdloff, Christina Wang · 2 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Androgen #Androgen deficiency #Cancer #Dihydrotestosterone #Endocrinology #Hormonal and reproductive studies #Hormone #Internal medicine #Medicine #Population #Prostate #Prostate Cancer Treatment and Research #Prostate cancer #Sexual Differentiation and Disorders #Testosterone (patch)

paper · doi:10.1016/s0950-351x(98)80267-x

crossref issued 1998/10/01 · crossref published 1998/10/01 · crossref published-print 1998/10/01 · openalex publication_date 1998/10/01 · crossref created 2005/03/11 · crossref deposited 2019/01/27 · crossref indexed 2025/10/09 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/15

Citations

• Tissue Distribution and Quantitative Analysis of Estrogen Receptor-α (ERα) and Estrogen Receptor-β (ERβ) Messenger Ribonucleic Acid in the Wild-Type and ERα-Knockout Mouse
• Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
• Tissue Distribution and Quantitative Analysis of Estrogen Receptor- (ER ) and Estrogen Receptor- (ER ) Messenger Ribonucleic Acid in the Wild-Type and ER -Knockout Mouse

Cited by

• Dihydrotestosterone treatment rescues the decline in protein synthesis as a result of sarcopenia in isolated mouse skeletal muscle fibres
• Dihydrotestosterone [wikipedia]